Targeting high-sensitivity C-reactive protein levels in acute coronary syndrome patients undergoing contemporary lipid-lowering therapy: a sub-analysis of the HIJ-PROPER trial-Reference-Cited by-同舟云学术

Targeting high-sensitivity C-reactive protein levels in acute coronary syndrome patients undergoing contemporary lipid-lowering therapy: a sub-analysis of the HIJ-PROPER trial

Published:2020-05 Issue:5 Volume:75 Page:500-506
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Kawada-Watanabe Erisa,Yamaguchi Junichi,Sekiguchi Haruki,Arashi Hiroyuki,Ogawa Hiroshi,Hagiwara Nobuhisa

Funder

Japan Research Promotion Society for Cardiovascular Diseases, Tokyo, Japan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels;Tello-Montoliu;J Intern Med,2007

2. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies;He;Heart,2010

3. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease;Lindahl;N Engl J Med,2000

4. Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment;Dibra;Eur Heart J,2003

5. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein;Ridker;N Engl J Med,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study;Journal of Clinical Lipidology;2024-06

2. Baseline high-sensitivity C-reactive protein and glycosylated hemoglobinA1c predict adverse outcomes in patients with chronic coronary syndromes undergoing percutaneous coronary intervention;Heliyon;2024-01

3. A Retrospective Clinical Study on Cardiovascular Complications from Colorectal Cancer;The Heart Surgery Forum;2023-12-26

4. Emerging Biomarkers in Acute Coronary Syndromes – A Pathophysiologic Perspective;Heart, Lung and Circulation;2022-06

5. The Effect of Statin Therapy on Inflammatory Biomarkers: A Systematic Review;Cureus;2021-09-25